Align Technology (ALGN): analysis and statistics
Return, volatility, Sharpe ratio and risk for Align Technology, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $153.62 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | -7.03% |
| Total return over period | -19.55% |
| Annualized volatility | 44.19% |
| Period volatility | 76.34% |
| Period T-bill | 12.40% |
| Sharpe ratio | -0.42 |
| Sortino ratio | -0.55 |
| Max drawdown | -62.19% |
| CVaR 95% (avg. loss, worst 5% of days) | -5.89% |
| Correlation with the S&P 500 | 0.45 |
| Period range | $124.88 – $330.25 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Align Technology (ALGN) has posted an annualized return of -7.03% with annual volatility of 44.19%, a negative Sharpe ratio: over this period it did not beat the risk-free Treasury rate. Its worst stretch (max drawdown from a peak) was -62.19%. Its correlation with the S&P 500 is 0.45, which means it moves moderately in step with the index.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how ALGN would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with ALGN →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Align Technology (ALGN) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio